CELC
Celcuity Inc.
NASDAQ · Healthcare · Biotechnology · US
$57.12
+0.95%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$1.43
- Revenue estimate
- $2.4M
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$1.44
- EPS estimate
- -$1.16
- Revenue actual
- —
- Revenue estimate
- $4.4M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +0.9%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $158
- PT range
- $134 – $177
- Analysts
- 6
6 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$1.16 | -$1.44 | Miss -24.14% | — |
| May 14, 2026 | -$1.07 | -$0.97 | Beat 9.35% | — |
| Mar 25, 2026 | -$1.06 | -$0.97 | Beat 8.49% | — |
| Nov 12, 2025 | -$1.02 | -$0.92 | Beat 9.80% | — |
| Aug 14, 2025 | -$0.90 | -$1.04 | Miss -15.56% | — |
| May 14, 2025 | -$0.95 | -$0.86 | Beat 9.47% | — |
| Mar 31, 2025 | -$0.72 | -$0.85 | Miss -18.06% | $121.3K |
| Nov 14, 2024 | -$0.65 | -$0.70 | Miss -7.69% | — |
| Aug 14, 2024 | -$0.71 | -$0.62 | Beat 12.68% | — |
| May 15, 2024 | -$0.71 | -$0.64 | Beat 9.86% | — |
| Nov 13, 2023 | -$0.74 | -$0.83 | Miss -12.16% | — |
| Aug 10, 2023 | -$0.67 | -$0.66 | Beat 1.49% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026